ABIOMED, Inc. (ABMD)
The Company is a provider of medical devices in circulatory support and offer a continuum of care in heart recovery to acute heart failure patients.
Recs
I really like these technicals and if it gets some volume and starts breaking its resistance around $9 I can see it going to 11 or 12. We'll see, it's a maybe.
Recs
I simply used the screener to identify 1-star companies with the highest 52-week gain. The 1-star rating should mean they are bad companies and the 52-week gain should mean they are overpriced. We’ll see how it works!
Recs
Has the first total transplantable artificial heart. This company has the innovation to create more medical products that will soon be approved and used.
Recs
short term pick, equity nr. 2 list
Recs
Testing a portfolio of companies that start with the letter "A".
Recs
On a strictly technical basis, my magic charts say this will outperform the S&P
Recs
Once the Impella 2.5 & 5 get FDA approval in the US (patient erollment for study complete; Canadian and European approval already achieved) they will start making money and you will see this stock boom. Get in now while it's still cheap.
Recs
This one is volatile; it is trading at 327% intrinsic value, although we may see the price climb higher before it finally goes back down.
Recs
Recs
New product line acquired last year propelling expanded cardiac treatment suite


RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 10 of 10